what are the Recommendations for Choice of SAVR Versus TAVI for Patients for
Whom a Bioprosthetic AVR Is Appropriate?
For symptomatic patients with severe AS for whom predicted post-TAVI or post-SAVR survival is <12 months or for whom minimal improvement in quality of life is expected, palliative care is recommended after shared decision-making, including discussion of patient preferences and values.